CF101 1 mg
CF101-301RA
Phase 3 small_molecule terminated
Quick answer
CF101 1 mg for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Can-Fite BioPharma
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated